DK64592D0 - Peptider til terapeutisk behandling - Google Patents

Peptider til terapeutisk behandling

Info

Publication number
DK64592D0
DK64592D0 DK92645A DK64592A DK64592D0 DK 64592 D0 DK64592 D0 DK 64592D0 DK 92645 A DK92645 A DK 92645A DK 64592 A DK64592 A DK 64592A DK 64592 D0 DK64592 D0 DK 64592D0
Authority
DK
Denmark
Prior art keywords
peptides
therapeutic treatment
therapeutic
treatment
Prior art date
Application number
DK92645A
Other languages
English (en)
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Priority to DK92645A priority Critical patent/DK64592D0/da
Publication of DK64592D0 publication Critical patent/DK64592D0/da
Priority to JP51722093A priority patent/JP3520084B2/ja
Priority to PT99101349T priority patent/PT960886E/pt
Priority to EP99101349A priority patent/EP0960886B1/en
Priority to PCT/GB1993/000649 priority patent/WO1993020102A1/en
Priority to UA94095852A priority patent/UA41881C2/uk
Priority to DK99101349T priority patent/DK0960886T3/da
Priority to CA002132516A priority patent/CA2132516A1/en
Priority to DE69329023T priority patent/DE69329023T2/de
Priority to AU38953/93A priority patent/AU684713B2/en
Priority to AT93907942T priority patent/ATE194495T1/de
Priority to AT99101349T priority patent/ATE267838T1/de
Priority to ES93907942T priority patent/ES2149203T3/es
Priority to US08/302,829 priority patent/US5756449A/en
Priority to ES99101349T priority patent/ES2222625T3/es
Priority to DE69333537T priority patent/DE69333537T2/de
Priority to DK93907942T priority patent/DK0635027T3/da
Priority to EP93907942A priority patent/EP0635027B1/en
Priority to KR1019940703264A priority patent/KR100312300B1/ko
Priority to AU63542/98A priority patent/AU725680B2/en
Priority to AU22549/99A priority patent/AU718442B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92645A 1992-03-27 1992-05-14 Peptider til terapeutisk behandling DK64592D0 (da)

Priority Applications (21)

Application Number Priority Date Filing Date Title
DK92645A DK64592D0 (da) 1992-05-14 1992-05-14 Peptider til terapeutisk behandling
EP93907942A EP0635027B1 (en) 1992-03-27 1993-03-29 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
DE69329023T DE69329023T2 (de) 1992-03-27 1993-03-29 T-peptid und damit verwandte peptide in der behandlung von entzündungen einschliesslich der multiplen sklerose
AT93907942T ATE194495T1 (de) 1992-03-27 1993-03-29 T-peptid und damit verwandte peptide in der behandlung von entzündungen einschliesslich der multiplen sklerose
EP99101349A EP0960886B1 (en) 1992-03-27 1993-03-29 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
PCT/GB1993/000649 WO1993020102A1 (en) 1992-03-27 1993-03-29 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
UA94095852A UA41881C2 (uk) 1992-03-27 1993-03-29 Лікарській засіб для лікування або профілактики запалення та спосіб лікування або профілактики запалення (варіанти)
DK99101349T DK0960886T3 (da) 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose
CA002132516A CA2132516A1 (en) 1992-03-27 1993-03-29 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
JP51722093A JP3520084B2 (ja) 1992-03-27 1993-03-29 多発性硬化症を含めた炎症の治療におけるペプチドｔ及びその関連ペプチド類
AU38953/93A AU684713B2 (en) 1992-03-27 1993-03-29 Peptide T and related peptides in the treatment of inflammatory bowel disease
PT99101349T PT960886E (pt) 1992-03-27 1993-03-29 Peptido t e peptidos relacionados no tratamento de inflamacao; incluindo esclerose multipla
AT99101349T ATE267838T1 (de) 1992-03-27 1993-03-29 T-peptid und damit verwandte peptide in der behandlung von entzündungen einschlies slich der multiplen sklerose
ES93907942T ES2149203T3 (es) 1992-03-27 1993-03-29 Peptido t y peptidos asociados destinados para el tratamiento de las inflamaciones, particularmente la esclerosis multiple.
US08/302,829 US5756449A (en) 1992-05-14 1993-03-29 Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
ES99101349T ES2222625T3 (es) 1992-03-27 1993-03-29 Peptido t y peptidos asociados destinados al tratamiento de la inflamacion incluyendo la esclerosis multiple.
DE69333537T DE69333537T2 (de) 1992-03-27 1993-03-29 T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose
DK93907942T DK0635027T3 (da) 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
KR1019940703264A KR100312300B1 (ko) 1992-03-27 1994-09-17 다발성경화증을포함한염증치료에있어서의펩타이드t및관련펩타이드
AU63542/98A AU725680B2 (en) 1992-03-27 1998-04-22 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
AU22549/99A AU718442B2 (en) 1992-03-27 1999-03-31 Use of peptide T in the treatment of multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92645A DK64592D0 (da) 1992-05-14 1992-05-14 Peptider til terapeutisk behandling

Publications (1)

Publication Number Publication Date
DK64592D0 true DK64592D0 (da) 1992-05-14

Family

ID=8095946

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92645A DK64592D0 (da) 1992-03-27 1992-05-14 Peptider til terapeutisk behandling

Country Status (2)

Country Link
US (1) US5756449A (da)
DK (1) DK64592D0 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
US6037324A (en) * 1996-01-04 2000-03-14 Leukosite, Inc. Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
WO1997036614A1 (en) * 1996-03-29 1997-10-09 Terman David S Polymerized staphylococcal protein a for treatment of diseases
US6255280B1 (en) 1999-04-08 2001-07-03 University Of Kentucky Research Foundation Protection against traumatic brain injury
US20040220103A1 (en) * 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
AR039241A1 (es) * 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US7700115B2 (en) 2005-06-23 2010-04-20 Rapid Pharmaceuticals Ag Therapeutic peptides and vaccines
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2010042933A2 (en) 2008-10-10 2010-04-15 Northwestern University Inhibition and treatment of prostate cancer metastasis
US10501494B2 (en) 2013-04-26 2019-12-10 Creative Bio-Peptides Uses of peptides to treat brain injury and disease
US9839625B2 (en) 2014-11-06 2017-12-12 Northwestern University Inhibition of cancer cell motility
USRE50630E1 (en) 2017-10-31 2025-10-14 Creative BioPeptides, Inc. Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7544987A (en) * 1986-06-03 1988-01-11 Pert, C.B. Small peptides which inhibit binding to t-4 receptors

Also Published As

Publication number Publication date
US5756449A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
DK64592D0 (da) Peptider til terapeutisk behandling
FI960584A7 (fi) Terapeuttisia peptidijohdannaisia
DK1266965T3 (da) Rekombinante antistoffer til human terapi
FI920737A7 (fi) Terapeuttisia peptidejä
FI922785A7 (fi) Terapeuttisia valmisteita
FI943018A7 (fi) Terapeuttisia aineita
NO933878D0 (no) Ultrasonisk behandlingssystem
DE69309164D1 (de) Mehrelektrischen Plasma Behandlungsgerät
FI952204A7 (fi) Terapeuttisia aineita
DK19893D0 (da) Praeparat til nasal behandling
FI961630A7 (fi) Terapeuttisia aineita
FI925530A7 (fi) Rekombinanttisesti tuotetut lipaasit terapeuttiseen käyttöön
KR950700707A (ko) 치과용 치료시스템
FI950545L (fi) Käsittelylaite
FI924744A7 (fi) Terapeuttisia aineita
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
FI943020A7 (fi) Terapeuttisia aineita
DK48993D0 (da) Forstoevningsapparat til vandbaaret lungemedicin
DE59301768D1 (de) Zahnbehandlungseinheit
FI923662A7 (fi) Terapeuttisia aineita
DK0623011T3 (da) Forstøvningsindretning til terapeutiske substanser
KR930023054U (ko) 맛사지기
FI952205L (fi) Terapeuttisia aineita
KR940009398U (ko) 척추 교정기
DE69326548D1 (de) Therapeutische kombinationen

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment